Mr. Lee has over 15 years of strategic finance and advisory experience in the biotechnology industry. During his career, he has helped raise over $1 billion of capital and worked on more than $20 billion of M&A transactions, including partnerships, asset acquisitions, mergers, spin-offs, and royalty monetizations.
Prior to Vaxart, Mr. Lee was Chief Financial Officer and Chief Operating Officer at Clover Biopharmaceuticals and Vice President, Finance at 4D Molecular Therapeutics. Mr. Lee began his career as an investment banker and was a founding member of Centerview Partners’ healthcare advisory practice.
Mr. Lee earned dual bachelor’s degrees in Electrical Engineering and Computer Sciences and Business Administration from the University of California, Berkeley.
